Sökresultat

He was best friends with Mikael Dolsten in Medical School in Lund in the 80´s. Since then he has held prominent positions around the world, both within Academia and the Medical Industry. Now he hopes to contribute to medical research with his experience in both basic and applied medicine, by helping to highlight the all-important, but in Lund a bit neglected, field of Pharmacology. Meet EMV´s new

https://www.medicine.lu.se/article/guest-professor-hoping-infuse-new-life-medical-cornerstone-field - 2026-07-01

It was Dolly the sheep that decided the fate of Filipe Pereira's future career. The choice lay between becoming an architect or a researcher, when one of the world's most extreme examples of cell reprogramming aroused his curiosity about the inner works of the human body. – I was in high school when I heard about Dolly the sheep, which fascinated me! How can a single, mature cell give rise to an e

https://www.medicine.lu.se/article/dolly-sheep-inspired-him-build-trojan-horse - 2026-07-01

A large population study from Lund University in Sweden has shown that more sustainable dietary habits are linked to health benefits, such as a reduced risk of premature death from cardiovascular disease and cancer. The study is published in The American Journal of Clinical Nutrition. “Our results indicate that dietary guidelines that are beneficial for both planetary health and personal health do

https://www.medicine.lu.se/article/environmentally-sustainable-diet-linked-health-benefits - 2026-07-01

One of the world’s leading researchers in the field of magnetic resonance imaging, Professor Peter C.M. van Zijl, and Stig Ålund, whose efforts have been of great importance for research on the elderly, ageing and health, are to be honorary doctors at the Faculty of Medicine. They will be formally recognised in Lund Cathedral on 3 June 2022. Professor Peter C.M. van Zijl was born in Amsterdam and

https://www.medicine.lu.se/article/new-honorary-doctors-faculty-medicine - 2026-07-01

Using methods for reprogramming human glia cells top create specialised nerve cells, interneurons, researcher Daniella Rylander Ottosson aims to lay the foundations for future treatments of diseases such as schizophrenia and epilepsy. Of the 27 new Wallenberg Academy Fellows, two are at Lund University: Daniella Rylander Ottosson, who is conducting research into regenerative neurophysiology at the

https://www.medicine.lu.se/article/daniella-rylander-ottosson-named-wallenberg-academy-fellow - 2026-07-01

The logopedics study programme at the Faculty of Medicine celebrated its 50th anniversary this year. Professor Birgitta Sahlén and Programme Director and Associate Professor Kristina Hansson look back to when it all began, talk about the current study programme – and look to the future. The logopedics study programme in Lund was the second one to begin in Sweden, and it is estimated that around 80

https://www.medicine.lu.se/article/logopedics-study-programme-celebrates-anniversary - 2026-07-01

Researchers at Lund University in Sweden have compared the effects of intravenous ketamine treatment with ECT treatment in severe depression. The results support the view that ketamine is a possible treatment, but also show that ECT treatment helps more people. In recent years, ketamine has emerged as a new treatment for depression, after studies have shown it to be a fast-acting antidepressant. “

https://www.medicine.lu.se/article/ect-more-effective-ketamine-severe-depression - 2026-07-01

Previous research from Lund University has shown that diabetes can be divided into five groups with different disease progression. A new study published in Nature Genetics demonstrates that there are also genetic differences between different groups of patients. An important goal of the research is to contribute with knowledge that will enable tailored treatments of patients with type 2 diabetes.

https://www.medicine.lu.se/article/new-research-highlights-genetic-differences-between-different-forms-type-2-diabetes - 2026-07-01

A lot of research explains which diets may reduce the risk of developing type 2 diabetes. Much research remains to be done about how our genes respond to the foods we eat. A new study led by researchers at Lund University adds to evidence that variations in the AMY1 gene may affect the way the body breaks down starchy foods. Unhealthy food habits are risk factors for developing type 2 diabetes. An

https://www.medicine.lu.se/article/bread-study-examines-role-genes-breaking-down-food - 2026-07-01

...showing that competitors in the Vasaloppet cross-country ski race run a lower risk of suffering from anxiety than the general population. Your results have been reported by the New York Times, CNN and many other international news outlets. Published in September last year, the article Physical Activity Is Associated With Lower Long-Term Incidence of Anxiety in a Population-Based, Large-Scale St

https://www.medicine.lu.se/article/hello-professor-tomas-deierborg-and-congratulations-considerable-international-attention-attracted - 2026-07-01

Immune Thrombocytopenia, ITP, is an autoimmune bleeding disorder that is still treated with immunosuppressive drugs that cause serious side effects. Professor John Semple’s laboratory studies the pathophysiological mechanisms behind this disease and together with Dr. Drew Provan, London, UK, has recently published the newest ideas on pathological mechanisms and therapies for the treatment and mana

https://www.medicine.lu.se/article/new-therapies-itp - 2026-07-01

Researchers in Lund have discovered an antitoxin mechanism that seems to be able to neutralise hundreds of different toxins and may protect bacteria against virus attacks. The mechanism has been named Panacea, after the Greek goddess of medicine whose name has become synonymous with universal cure. The understanding of bacterial toxin and antitoxin mechanisms will be crucial for the future success

https://www.medicine.lu.se/article/new-multipurpose-switch-inhibiting-bacterial-growth - 2026-07-01

In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionised areas of cancer care. However, there are still significant challenges in the identification of cancer cell surface proteins as targets for immunotherapies. A research group

https://www.medicine.lu.se/article/new-precision-technology-immunotherapy - 2026-07-01

We ended the MultiPark year in December as we started it in January: with a MultiPark Retreat! The December retreat was our first big meeting IRL after the pandemic, and it turned out to be a much appreciated event. Thank you to all participants, and thank you once again to the retreat organizing committee for doing such a great job! 2022 was a year of “reopening”. Like a butterfly spreads its win

https://www.multipark.lu.se/article/multipark-closing-circle-2022-and-looking-forward-2023 - 2026-07-01

Katrine Skovgård’s Ph.D. project sheds light on the dysfunctions in the brain through which dopaminergic pharmacotherapies for Parkinson’s disease affect motor behaviors. January 19, she defends her thesis. She explains how better experimental models might improve future translational research on dyskinesia. You presented your research at the MultiPark Café recently. But for those who could not at

https://www.multipark.lu.se/article/why-dopamine-receptor-type-matters-phd-interview-katrine-skovgard - 2026-07-01

At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disease. The cells, generated from embryonic stem cells, have been in development for several years and will now be transplanted into patients with Parkinson’s to replace nerve cells lost due to the disease. The clinical tria

https://www.multipark.lu.se/article/nerve-cells-could-transform-treatment-parkinsons - 2026-07-01

Huntington's disease is known as the "dance disease" due to the patient's characteristic motor symptoms. However, Elna Dickson's Ph.D. project shows that the disease also leads to pathological changes outside the brain. February 17, she defends her thesis about metabolic alterations in Huntington's disease. Now, she shares perspectives on her research journey. Tell us about your research! "Hunting

https://www.multipark.lu.se/article/huntingtons-metabolic-dysfunctions-phd-interview-elna-dickson - 2026-07-01

The aggregation of the protein Amyloid-beta (Abeta) into plaques outside the nerve cells has been recognized in patients with Alzheimer’s disease since 1905. But eliminating the plaques has not helped patients so far. Still, Tomas Roos thinks that Abeta matters, but we may need to focus on the aggregates elsewhere. On February 17, he defends his thesis about prion-like proteins in neurodegeneratio

https://www.multipark.lu.se/article/does-alzheimers-disease-start-inside-neurons-phd-interview-tomas-roos - 2026-07-01

On 13th of February, a transplant of stem cell-derived nerve cells was administered to a person with Parkinson’s at Skåne University Hospital, Sweden. The product has been developed by Lund University and it is now being tested in patients for the first time. The transplantation product is generated from embryonic stem cells and functions to replace the dopamine nerve cells which are lost in the p

https://www.multipark.lu.se/article/first-patient-receives-milestone-stem-cell-based-transplant-parkinsons-disease - 2026-07-01

The boundaries between biology and technology are becoming blurred. Researchers at Linköping, Lund, and Gothenburg universities in Sweden have successfully grown electrodes in living tissue using the body’s molecules as triggers. The result, published in the journal Science, paves the way for the formation of fully integrated electronic circuits in living organisms. This news was initially publish

https://www.multipark.lu.se/article/electrodes-grown-brain - 2026-07-01